Grey Wolf Health (TSXV:WOLF) Total Receivables: C$1.98 Mil (As of Mar. 2026)


TSXV:WOLF Grey Wolf Health Corp TSXV:WOLF
52 GF Score
Price C$1.75
GF Value C$1.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Health Total Receivables?

Grey Wolf Health TSXV:WOLF -1.69% 52 Total Receivables is C$1.98 Mil as of Mar. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 52/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Grey Wolf Health's Total Receivables for the quarter that ended in Mar. 2026 was C$1.98 Mil.

Grey Wolf Health Total Receivables Related Terms

Grey Wolf Health Total Receivables Historical Data

* Premium members only.

The historical data trend for Grey Wolf Health's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health Total Receivables Chart

Grey Wolf Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
1.13 1.95 1.69 2.21 2.25

Grey Wolf Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 2.94 3.21 2.25 1.98
TSXV:WOLF
52GF Score
Grey Wolf Health Corp TSXV:WOLF
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Wolf Health Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of C$1.98 Mil mean?
Grey Wolf Health (TSXV:WOLF) has a Total Receivables of C$1.98 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Grey Wolf Health and its competitors.
Is Grey Wolf Health's Total Receivables too high?
Grey Wolf Health's current Total Receivables is C$1.98 Mil. Overall, Grey Wolf Health has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's Total Receivables compare to ROL and SCI?
Grey Wolf Health's Total Receivables of C$1.98 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Grey Wolf Health and its competitors. Grey Wolf Health's current Total Receivables is C$1.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.75 — trading 59.1% above its estimated fair value. The current Total Receivables is C$1.98 Mil. Grey Wolf Health's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current Total Receivables is C$1.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued. The current stock price of C$1.75 is trading 59.1% above its estimated GF Value™ of C$1.10. GuruFocus considers Grey Wolf Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • Total Receivables: C$1.98 Mil
  • GF Value™: C$1.10 vs. price of C$1.75 (59.1% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grey Wolf Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
52GF Score

Get the complete analysis for TSXV:WOLF

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.75
Price
C$1.10
GF Value